New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Autolus Therapeutics plc
AUTL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

455M

Biotechnology

Next Earning date - 16 May 2025

455M

Biotechnology

Next Earning date - 16 May 2025

2.04USD

Shape0.10 ( 5.15%)
sun-fogPre-market 2.00$arrow-left-down-0.01 (-0.25%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

69%

Quote Panel

Shape
Updated March 25, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

AUTL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$37M

Shape126944%

2025-Revenue

$0.88

ShapeNaN%

2025-EPS

$37M

Shape33%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Goldman Sachs

upgrade

Previous: Not converted

2024-11-18

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.23
vs -0.41

Q2.23

arrow
arrow

N/A

-0.26
vs -0.46

Q3.23

arrow
arrow

N/A

-0.26
vs -0.47

Q4.23

arrow
arrow

N/A

-0.44
vs -0.23

Q1.24

arrow
arrow

N/A

-0.24
vs -0.23

Q2.24

arrow
arrow

N/A

-0.22
vs -0.26

Q3.24

arrow
arrow

N/A

-0.31
vs -0.26

Q4.24

arrow
arrow

N/A

-0.09
vs -0.44

Q1.25

arrow
arrow

N/A

-0.26
vs -0.24

Q2.25

arrow
arrow

N/A

-0.26
vs -0.22

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+678%

1.3M  vs 166K

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-83%

406K  vs 2.4M

Q4.23

arrow
arrow

-54%

1.8M  vs 3.8M

Q1.24

arrow
arrow

+681%

10.1M  vs 1.3M

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

-100%

NA  vs 406K

Q4.24

arrow
arrow

-98%

29K  vs 1.8M

Q1.25

arrow
arrow

-86%

1.4M  vs 10.1M

Q2.25

arrow
arrow

NA

5.3M  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-15%

-0.15
vs -0.09

Q2.23

arrow
arrow

-20%

-0.20
vs -0.15

Q3.23

arrow
arrow

-25%

-0.25
vs -0.20

Q4.23

arrow
arrow

-69%

-0.69
vs -0.25

Q1.24

arrow
arrow

-9%

-0.09
vs -0.69

Q2.24

arrow
arrow

-11%

-0.11
vs -0.09

Q3.24

arrow
arrow

-17%

-0.17
vs -0.11

Q4.24

arrow
arrow

-6%

-0.06
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

66

66
vs 72

-8%

Q2.23

arrow
arrow

70

70
vs 66

6%

Q3.23

arrow
arrow

70

70
vs 70

NA

Q4.23

arrow
arrow

100

100
vs 70

43%

Q1.24

arrow
arrow

123

123
vs 100

23%

Q2.24

arrow
arrow

112

112
vs 123

-9%

Q3.24

arrow
arrow

101

101
vs 112

-10%

Q4.24

arrow
arrow

107

107
vs 101

6%

Earnings Growth

Latest News